ProtoKinetix, Incorporated (PKTX)

OTCMKTS · Delayed Price · Currency is USD
0.0061
+0.0002 (3.67%)
Mar 9, 2026, 11:53 AM EST
-58.10%
Market Cap 2.39M
Revenue (ttm) n/a
Net Income (ttm) -376.17K
Shares Out 407.68M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 500
Average Volume 267,825
Open 0.0061
Previous Close 0.0059
Day's Range 0.0061 - 0.0061
52-Week Range 0.0040 - 0.0149
Beta 0.52
RSI 47.37
Earnings Date Feb 18, 2026

About ProtoKinetix

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). Its AFGPs are used in various commercial applications comprising targeted health care solutions, as well as AAGPs are used for applications in ophthalmology, dermatology, transplants, and biomanufacturing areas. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incor... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 5
Stock Exchange OTCMKTS
Ticker Symbol PKTX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.